APA (7th ed.) Citation

Kayvanpour, E., Sedaghat-Hamedani, F., Li, D. T., Miersch, T., Weis, T., Hoefer, I., . . . Meder, B. (2024). Prognostic value of circulating fibrosis biomarkers in dilated cardiomyopathy (DCM): Insights into clinical outcomes. Biomolecules, 14(9), . https://doi.org/10.3390/biom14091137

Chicago Style (17th ed.) Citation

Kayvanpour, Elham, Farbod Sedaghat-Hamedani, Daniel Tian Li, Tobias Miersch, Tanja Weis, Imo Hoefer, Norbert Frey, and Benjamin Meder. "Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes." Biomolecules 14, no. 9 (2024). https://doi.org/10.3390/biom14091137.

MLA (9th ed.) Citation

Kayvanpour, Elham, et al. "Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes." Biomolecules, vol. 14, no. 9, 2024, https://doi.org/10.3390/biom14091137.